GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CHC Healthcare Group (TPE:4164) » Definitions » YoY EBITDA Growth

CHC Healthcare Group (TPE:4164) YoY EBITDA Growth : -20.91% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is CHC Healthcare Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CHC Healthcare Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -20.91%.

CHC Healthcare Group's EBITDA per Share for the three months ended in Mar. 2024 was NT$1.13.


CHC Healthcare Group YoY EBITDA Growth Historical Data

The historical data trend for CHC Healthcare Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHC Healthcare Group YoY EBITDA Growth Chart

CHC Healthcare Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.87 -14.22 11.90 0.64 16.81

CHC Healthcare Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.94 11.65 -7.41 57.52 -20.91

CHC Healthcare Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CHC Healthcare Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(6.421-5.497)/ | 5.497 |
=16.81 %

CHC Healthcare Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(1.131-1.43)/ | 1.43 |
=-20.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CHC Healthcare Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


CHC Healthcare Group (TPE:4164) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.

CHC Healthcare Group (TPE:4164) Headlines

No Headlines